EcoDrugPlus

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSECRG00000021379
Gene Symbol: APH1B
3 Cross references
186 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSECRG00000002702
Gene Symbol: APEX1
3 Cross references
214 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSECRG00000008715
Gene Symbol: ALOX12
1 Cross references
196 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSECRG00000008107
Gene Symbol: ALOX5
3 Cross references
223 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSECRG00000004114
Gene Symbol: ALOX5AP
3 Cross references
201 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSECRG00000008563
Gene Symbol: LOC114648751
3 Cross references
196 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSECRG00000009070
Gene Symbol: LOC114648756
3 Cross references
196 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSECRG00000008889
Gene Symbol: LOC114648752
3 Cross references
196 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSECRG00000007790
Gene Symbol: LOC114648754
3 Cross references
196 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSECRG00000010914
Gene Symbol: AVPR1A
3 Cross references
268 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSECRG00000004200
Gene Symbol: AVPR1B
3 Cross references
138 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSECRG00000010459
Gene Symbol: AVPR2
3 Cross references
234 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).